Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Camber – Recall of Montelukast
August 31, 2018 - The FDA announced a voluntary, patient-level recall of one lot of Camber’s montelukast 10 mg tablets because sealed bottles were found to contain losartan 50 mg tablets.
